Coronavirus

Coronavirus Testing Begins at the Weizmann Institute of Science

Fluhr Incpm
Prof. Robert Fluhr, director of the Nancy and Stephen Grand Israel National Center for Personalized Medicine at the Weizmann Institute of Science, receives the Institute’s first shipment of tests

REHOVOT, ISRAEL—April 12, 2020—Following an agreement signed this morning between Israel’s Ministry of Health and the Weizmann Institute of Science, the Institute started conducting tests today diagnose coronavirus. The tests will be carried out at the Nancy and Stephen Grand Israel National Center for Personalized Medicine, established by and operating at the Weizmann Institute of Science. The Grand Center’s world-class, cutting-edge lab facilities include advanced polymerase chain reaction (PCR) systems, which are capable of rapid and efficient gene identification.

The President of the Weizmann Institute of Science, Prof. Alon Chen, said: “As an integral part of Israeli society, we at the Weizmann Institute of Science consider it our duty and privilege to help and contribute to the State and the people of Israel in coping with the global coronavirus crisis. During this time of emergency, we are harnessing our basic research capabilities for the benefit of humanity.”

Coronavirus

Coronavirus Testing Begins at the Weizmann Institute of Science

• TAGS: Virus , Biology , Culture , Technology

Fluhr Incpm
Prof. Robert Fluhr, director of the Nancy and Stephen Grand Israel National Center for Personalized Medicine at the Weizmann Institute of Science, receives the Institute’s first shipment of tests

REHOVOT, ISRAEL—April 12, 2020—Following an agreement signed this morning between Israel’s Ministry of Health and the Weizmann Institute of Science, the Institute started conducting tests today diagnose coronavirus. The tests will be carried out at the Nancy and Stephen Grand Israel National Center for Personalized Medicine, established by and operating at the Weizmann Institute of Science. The Grand Center’s world-class, cutting-edge lab facilities include advanced polymerase chain reaction (PCR) systems, which are capable of rapid and efficient gene identification.

The President of the Weizmann Institute of Science, Prof. Alon Chen, said: “As an integral part of Israeli society, we at the Weizmann Institute of Science consider it our duty and privilege to help and contribute to the State and the people of Israel in coping with the global coronavirus crisis. During this time of emergency, we are harnessing our basic research capabilities for the benefit of humanity.”